Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(38%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

completed450%
unknown113%
recruiting338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8